NCT04830865

Brief Summary

Increased life expectancy leads to population aging, increased morbidities and aging of hospitalized patients. The acquisition of frailty leads to worse outcomes derived from hospitalization, but although frailty has been related to aging, young patients admitted to Intensive Care Units (ICU) with frailty have also been found to have worse outcomes than non-frail patients. This unfavorable evolution could be related to the acquisition of the post-uci syndrome (physical, mental and cognitive sequelae at discharge from the ICU), since high frailty scores favor this syndrome. The use of frailty scales on admission to the ICU could provide early detection of patients most likely to develop post-ICU syndrome, regardless of age, and redirect our care to those who need it most. Some scales that measure frailty in elderly patients have been used in the ICU, but although they have been validated in their original language, they need to be adapted and validated in Spanish. Objectives. Adaptation and validation of the Clinical Frailty Scale (CFS) and the FRAIL Scale in ICU patients of different ages, in women and in men. Methodology. Study developed in two phases.Phase 1, adaptation to Spanish of the scales (translation, pilot, back-translation, correlation); Phase 2, analysis of their metric properties (Validity, Reliability, Sensitivity, Minimum important difference) by means of a multicenter observational study (7 ICUs in Spain), prospective, descriptive, of a cohort of critical patients with one-year follow-up (at 3, 6, 9 and 12 months after hospital discharge).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
512

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Sep 2019

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 15, 2019

Completed
1.5 years until next milestone

First Submitted

Initial submission to the registry

March 25, 2021

Completed
11 days until next milestone

First Posted

Study publicly available on registry

April 5, 2021

Completed
3.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 5, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 5, 2024

Completed
Last Updated

March 13, 2025

Status Verified

March 1, 2025

Enrollment Period

5.1 years

First QC Date

March 25, 2021

Last Update Submit

March 10, 2025

Conditions

Keywords

Frailtycritical caregenderreliabilityvaliditystudy transculturalquality of life

Outcome Measures

Primary Outcomes (1)

  • Fragility scales's validation

    100% scale sensitivity

    2 years

Secondary Outcomes (6)

  • Obtaining adapted scales to patients in intensive care units in Spain

    6 months

  • Obtaining adapted scales to patients in intensive care units in Spain

    6 months

  • Assessment of the predictive, convergent and divergent validity of the scales obtained (with respect to the original ones)

    2 years

  • Assessment of the interobserver and intraobserver reliability of the scales obtained (with respect to the original ones)

    2 years

  • Assessment of the sensitivity to change of the scales obtained (with respect to the original ones)

    1 year

  • +1 more secondary outcomes

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All patients who remain hospitalized for more than 48 hours in any of the 8 Spanish intensive care units participating in the study, they will be candidates for inclusion in the study.

You may qualify if:

  • \- Critical care patients over 18 years who have given their consent personally.

You may not qualify if:

  • Patients admitted with a diagnosis of present or imminent brain death,
  • readmissions previously included,
  • patients whose expected stay is less than 48 hours
  • patients with comunication problems

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital Universitario de Getafe

Getafe, Madrid, 28905, Spain

Location

MeSH Terms

Conditions

FrailtyCoitus

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and SymptomsSexual BehaviorBehavior

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
12 Months
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

March 25, 2021

First Posted

April 5, 2021

Study Start

September 15, 2019

Primary Completion

October 5, 2024

Study Completion

October 5, 2024

Last Updated

March 13, 2025

Record last verified: 2025-03

Locations